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Background/aim: Autism is a heterogeneous neurodevelopmental disorder. This study aimed to assess the clinical significance of amino
acid profile assay in autism using cation-exchange chromatography with ninhydrin postcolumn derivatization.
Materials and methods: This study included 42 autistic children and 26 apparently healthy children. All participants were subjected to
the assay of plasma amino acids (essential, nonessential, and nonstandard) using cation-exchange chromatography with postcolumn
derivatization by ninhydrin.
Results: The levels of most of the essential amino acids were significantly lower in autistic children than controls. As regards nonessential
amino acids, significantly lower levels for plasma cysteine, tyrosine, and serine and significantly higher levels for plasma glutamic acid
were recorded in autistic children than controls. Finally, the autistic group demonstrated significantly lower levels of α-aminoadipic
acid, carnosine, and β-alanine and significantly higher levels of hydroxyproline, phosphoserine, β-amino-isobutyric acid, and ammonia
as compared to controls.
Conclusion: The study revealed that autistic children exhibit distinct alterations in the plasma levels of some amino acids, which can in
turn participate in the disease etiology and can be applied as a diagnostic tool for early detection of autism.
Key words: Autism, amino acids, cation-exchange chromatography

1. Introduction
Autism is a set of pervasive heterogeneous
neurodevelopmental disorders characterized by
early onset of impairment of reciprocal social
interactions and communication development along
with extremely restricted and repetitive stereotyped
behaviors (1). The worldwide prevalence of autism is
about 1% (2).
There is substantial evidence implicating genetic
heritability and environmental factors in addition
to oxidative stress, inflammation, and immune
dysregulation in the pathogenesis of autism. Although
no single coherent explanation has emerged (3), some
recent research studies suggested the implication of
abnormalities in plasma amino acids in the etiology
of autism (4–6).
The aim of the present study was to assess the
clinical significance of plasma amino acid profile assay
in autism using cation-exchange chromatography
with ninhydrin postcolumn derivatization.
* Correspondence: hala1abdelal@yahoo.com
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2. Material and methods
This study was conducted from February to August
2014 at the Medical Genetics Center, Ain Shams
University Hospitals, Cairo, Egypt. The study protocol
was approved by the ethical committee of the Faculty
of Medicine of Ain Shams University.
2.1. Subjects
The study included Group 1, which included 42 autistic
Egyptian children (34 males and 8 females), aged 2–14
years old. The diagnosis of autism was confirmed by
DSM-IV criteria (7). The diagnosis was in accordance
with Autism Diagnostic Interview-Revised (ADI-R) (8).
In addition, Group II included 26 age- and sex-matched
apparently healthy children serving as healthy controls.
Patients with psychotic disorders, active substance
dependence, evidence of liver disease, seizure disorder,
unstable hypertension, cardiac disease, or kidney disease
were excluded from the study. Each autistic child included
in the study was subjected to full history taking with special
stress on history of vaccinations, drug intake, infection,
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and developmental motor and mental milestones and
clinical examination with special emphasis on the
neurological examination and psychiatric evaluation.
All participants included in the study were subjected to
the quantitative determination of plasma amino acids
(essential, nonessential, and nonstandard amino acids).
2.2. Sampling
Three milliliters of overnight fasting venous blood was
withdrawn into sterile EDTA vacutainers under completely
aseptic conditions. Plasma was separated immediately by
centrifugation and was stored in aliquots at –80 °C until
the assay. Any hemolyzed or lipemic sample was discarded.
2.3. Amino acid assay
The quantitative determination of plasma amino acids was
performed by a high-performance liquid chromatography
(HPLC) technique using cation-exchange resin and
postcolumn derivatization with ninhydrin (9).
2.3.1. Sample preparation
An acid precipitation method was applied immediately for
the precipitation of proteins and peptides in the sample.
In this method, 800 µL of plasma was added to 200 µL of
sulphosalicylic acid (10%). After being stored at 4 °C for 30
min, the sample was centrifuged at 13,000 rpm for 10 min
and the resulting upper clear solution was dissolved in an
equal volume of the sample diluent buffer (lithium citrate).
If not analyzed immediately, the sample was stored at –80
°C.
2.3.2. Working external standards
Ready-to-use aqueous standard solutions were available
for all the measured amino acids. The stock solution of
the amino acids was prepared in 0.1% N HCL and 0.1%
phenol. The working standard solution was prepared by
adding 2 mL of the standard solution to 8 mL of sample
diluent buffer (pH 2.20); this was followed by preparation
of serial dilutions of the different working standards.
2.3.3. Ninhydrin preparation
First, 0.8 g of reducing agent hydrantin was dissolved in 30
mL of ethylene glycol monomethyl ether and was added to
the ninhydrin solution. The solution was then flushed with
N2 gas for 5 min in order to get rid of oxygen and dissolved
gases. The ninhydrin was then stored under continuous
nitrogen pressure for 2–3 days before the analysis.
2.3.4. Buffer system
The ready-to-use buffer system consisted of three lithium
buffers (A, B, and C) (i.e. lithium as the cationic counterion).
2.3.5. Chromatographic analysis
The assay was performed on the Sykam amino acid
analyzer (S-433; Eresing, Germany). The equipment
consisted mainly of a solvent delivery system with fully
programmable quaternary gradient pumps, a degasser

and reagent organizer to keep the solutions free of oxygen
and dissolved gases, an autosampler, a separation column
filled with cation-exchange resin, a reagent dosing pump
for ninhydrin delivery and flushing of the reaction coil
after each run, a high-temperature reactor for the color
reaction of the amino acid–ninhydrin complex, a dualchannel photometer for amino acid detection at 440 nm
and 570 nm wavelengths, and a software system for data
integration.
2.3.6. Principle of amino acid separation and
quantification
Amino acids are zwitterions that include both amino and
carboxyl groups in their structures. Therefore, the higher
the acidity (more likely to form anions) during the cation
exchange, the faster the elution, whereas the more basic
the solution, the slower the elution. Hence, the separation
of the mixture of amino acids is based on their partitioning
behavior between the buffer system and the stationary
phase. This phenomenon depends on the different pH
values of the buffer solutions, where the activity of buffer A
leads to the separation of amino acids from phosphoserine
up to glutamic acid, while the separation of α-aminoadipic
acid up to α-amino butyric acid is due to the mixture
between buffers A and B. The separation of amino acids
from valine up to tyrosine was due to the activity of
buffer B while the mixture between buffers B and C led
to the separation from phenylalanine up to tryptophan.
The activity of only buffer C led to the separation from
ammonia up to arginine. The quantification of amino acids
was based on the postcolumn derivatization of heated
amino acid with ninhydrin. All amino acids having a free
alpha amino group yield a purple product while proline,
which has an imino group, yields a yellow product. Under
appropriate conditions, the intensity of the color produced
is proportional to the amino acid concentration. The
chromatographic profile corresponding to the elution
pattern of different amino acids is shown in the Figure.
2.3.7. Calculation of results
The final concentrations of amino acids in the samples
were obtained from a calibration curve constructed by
plotting the peak area of different dilutions of working
external standards against their concentrations.
2.4. Statistical analysis
Statistical analysis was carried out on a personal computer
using SPSS 8 (SPSS Inc., Chicago, IL, USA). Nonparametric
qualitative data were expressed in numbers and percentages
while nonquantitative parametric data were expressed as
medians and interquartile ranges (IQRs). Comparative
statistics of qualitative data were obtained using the chisquare test while comparison of quantitative data was
done by Wilcoxon’s rank sum test. P < 0.05 was considered
significant and P < 0.01 was considered highly significant.
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Figure. The chromatographic profile corresponding to the elution pattern of different studied plasma amino acids.

3. Results
The results of the present study are shown in Tables 1–5.
Table 1 shows that 81% of the studied patients were male.
The age at onset of disease was below 3 years in 83.3% of
children. However, none of the children experienced any
antenatal insult and only 9.5% had a postnatal history
of fever, infection, fits, or hypoxia. The first alarming
manifestation in 66.7% of autistic children was delayed
speech, while others experienced loss of eye contact
(14.3%), 9.5% like to play alone, and 9.5% lost their
attention to their mothers.
Table 2 reveals the presence of a highly significant
difference between the groups as regards some clinical data
(P < 0.001), where 61.9% of autistic children had abnormal
social development, 76% had delayed continence, 61.9%
had stereotypic movements, 71.4% were hyperactive, and
71.4% had mild to moderate mental retardation.
Table 3 demonstrates a highly significant difference
between the groups as regards the essential amino acids
methionine, leucine, and phenylalanine (P < 0.01 for all),
while a significant difference was found in the levels of
isoleucine, histidine, tryptophan, and arginine (P < 0.05
for all), all being lower in patients as compared to controls.
As regards nonessential amino acids, statistical
comparison between the studied groups revealed the
presence of a highly significant difference in the level of
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cysteine (P < 0.01) and a significant difference in the levels
of tyrosine and serine (P < 0.05 for both), all being lower
in the autistic children as compared to healthy controls.
However, the plasma glutamic acid level was significantly
higher in autistic children than controls (Table 4).
Table 5 shows the descriptive and comparative statistics
of nonstandard amino acids between patients and control
group. Within the autistic group, significantly lower levels
were reported regarding α-aminoadipic acid and carnosine
(P < 0.01 for both) and β-alanine (P < 0.05). Meanwhile,
significantly higher levels of phosphoserine (P < 0.01) and
hydroxyproline, β-amino-isobutyric acid, and ammonia
(P < 0.05 for all) were recorded in autistic children.
4. Discussion
Analysis of the demographic data of autistic children
included in the present study revealed that most of autistic
patients were male. Similar finding were reported by
Chang et al. (10) and Majewka et al. (11), who suggested
that sex steroids may influence the expression of specific
genes in association with autism or may modulate the
activity of neurotransmitters in the brain. Moreover, 83%
of patients were diagnosed before the age of 3 years old
with no antenatal or postnatal history of insult exposure.
These data were consistent with those of Atladóttir et al.
(12) and Tu et al. (5).
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Table 1. Descriptive statistics of the demographic and clinical data of autistic patients.

Sex
Male
Age at onset
Less than 3 years
Antenatal history
Drug intake/STORCH infection/radiation exposure
Normal vaginal delivery
Postnatal history
Fever/infection/fits/hypoxia
First alarming specific manifestation
Delayed speech
Loss of eye contact
Likes to play alone
Inattention to mother

Number

%

34

81

35

83.3

0

0

33

78.6

4

9.5

28
6
4
4

66.7
14.3
9.5
9.5

Table 2. Descriptive and comparative statistics of the clinical data between patients and control group using
chi-square test.
Patient group
(n = 42)

Control group
(n = 26)

N

%

N

%

Delayed motor development
Head support/sitting/walking

6

14.3

2

Abnormal social development
Delayed waving ‘bye-bye’
Afraid of strangers
Delayed age of continence

26
28
32

61.9
66.7
76.2

Intolerance to pain

38

Stereotypic movements
Hypotonia/hyporeflexia

χ2

P-value

7.7

0.34

0.56

0
24
4

0
92.3
15.4

13.03
2.93
11.92

0.000**
0.08
<0.001**

90.5

0

0

26.66

0.000**

26

61.9

0

0

13.03

0.000**

8

19

0

0

2.81

0.09

Hyperactivity

30

71.4

2

7.7

11.04

<0.001**

Mild to moderate mental retardation

30

71.4

0

0

21.19

0.000**

**Highly significant difference.

Regarding the disease manifestations, all patients
included in the study had defects in communication
skills manifested mainly by delayed speech. In addition,
most of the patients had abnormal social development,
intolerance to pain, stereotypic repetitive movements,
hyperactivity, delayed continence, and mild to moderate
mental retardation. These findings are strengthened by
the works of other researchers (1,13,14) who concluded
that the previous findings represented the core symptoms
of autism with mental retardation being a common
comorbidity.

In the present study, the plasma amino acid profile
was assessed using cation-exchange chromatography with
postcolumn derivatization by ninhydrin. This technique
is the most preferred one for amino acid quantification
as it requires minimum sample preparation and ensures
elimination of interferences from the sample matrix prior
to quantification, thus providing maximum accuracy (9).
As regards the studied essential amino acids, the
present study elucidated the fact that autistic children are
suffering from essential amino acid deficiency, mainly
of methionine, tryptophan, leucine, phenylalanine,
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Table 3. Descriptive and comparative statistics of essential amino acids (nmol/mL) between
patients and control group using the Wilcoxon rank sum test.

Threonine

Patient group
(n = 42)

Control group
(n = 26)

Median (IQR)

Median (IQR)

19 (1.1–38)

Z

P-value

34 (8–52 .45)

–1.067

0.286

Valine

66 (40.5–84.5)

75 (42–123.5)

–1.453

0.146

Methionine

3.9 (0.9–9.3)

17 (10.1–23.5)

–3.262

0.001**

Isoleucine

13 (2.85–23.5)

29 (17.5–23)

–2.447

0.014*

Leucine

32 (8.75–45.5)

64 (49.5–85.5)

–3.314

0.001**

Lysine

27 (12.50–91)

66 (8.90–78)

–0.675

0.499

Phenylalanine

15 (9.8–32.5)

44 (34–53)

–3.387

0.001**

Histidine

0.01 (0.01–3.30)

9.40 (0.01–53.50)

–2.266

0.023*

Tryptophan

0.1 (0.01–0.95)

1.30 (0.35–5.0)

–2.167

0.03*

Arginine

0.1 (0.01–6.8)

16 (2–39)

–2.148

0.032*

IQR = Interquartile range.
**Highly significant difference, *significant difference.
Table 4. Descriptive and comparative statistics of nonessential amino acids (nmol/mL) between
patients and control group using the Wilcoxon rank sum test.

Aspartic acid

Patient group
(n = 42)

Control group
(n = 26)

Median (IQR)

Median (IQR)

2.3 (0.01–5.85)

Z

P-value

1.7 (0.30–7.75)

0.444

0.657

Serine

32 (5–54)

62 (26–131)

–2.144

0.032*

Asparagine

49 (0.05–289.5)

46 (0.01–186)

0.865

0.387

Glutamic acid

29 (10.0–90.5)

4.70 (0.10–23.5)

2.141

0.031*

Proline

0.1 (0.01–6.7)

5.2 (0.01–50.3)

–1.346

0.178

Glycine

86 (53–121)

89 (51–113.5)

–0.071

0.943

Alanine

95 (0.05–151)

185 (36–568)

–1.955

0.051

Tyrosine

11 (5.45–34.5)

33 (34–53)

–2.34

0.019*

Cysteine

0.1 (0.01–2.2)

14 (6.85–19)

–2.857

0.004**

IQR = Interquartile range.
**Highly significant difference, *significant difference.

isoleucine, histidine, and arginine. These results were
confirmed by Adams et al. (15), Tirouvanziam et al. (16),
and Tu et al. (5). Such deficiency is attributed to the presence
of gastrointestinal problems in autistic children such as
malabsorption, maldigestion, gastric dysfunction caused
by intrinsic factor deficiency or vitamin B12 deficiency,
and food intolerance in addition to their picky and selective
eating (17,18). As drawbacks of some essential amino
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acid deficiencies, Lakhan and Vieira (19) and KałużnaCzaplińska et al. (20) demonstrated that deficiency of the
amino acids tryptophan, phenylalanine, and methionine
can induce many mood disorders, including depression
and irritability. Naushad et al. (18) attributed such findings
to the fact that tryptophan is the precursor of serotonin;
moreover, they highlighted the importance of methionine
in the production of brain neurotransmitters and in the
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Table 5. Descriptive and comparative statistics of nonstandard amino acids (nmol/mL) between patients
and control group using the Wilcoxon rank sum test.

Phosphoserine

Patient group
(n = 42)

Control group
(n = 26)

Median (IQR)

Median (IQR)

7.7 (4.45–13.0)

3.1 (2.65–6.05)

Z

P-value

3.013

0.003**

Taurine

62 (46.5–117)

91.20 (62–170.5)

–1.666

0.096

β-Alanine

55 (0.01–377.5)

235 (68.5–796.5)

–2.012

0.044*

Phosphoethanolamine

0.01 (0.01–0.40)

0.10 (0.025–1.55)

–1.658

0.097

Urea

1261 (880.50–1622.5) 1204 (896.5–1885)

–0.23

0.818

Hydroxyproline

0.1 (0.01–1.4)

0.01 (0.01–0.01)

2.282

0.022*

Citrulline

0.01 (0.01–0.10)

0.01 (0.01–3.67)

–0.894

0.371

α-Aminoadipic acid

0.01 (0.01–0.10)

1.50 (0.01–79.35)

–2.445

0.014*

α-Aminobutyric acid

0.01 (0.01–0.45)

0.01 (0.01 – 0.01)

1.414

0.157

δ-Aminobutyric acid

7.9 (2.95–27.5)

11 (4.9 – 21.0)

1.17

0.242

β-Amino-isobutyric acid

12 (3.55–19)

3.6 (0.65 – 6.5)

2.093

0.031*

Carnosine

0.1 (0.01–0.70)

13 (0.11–33)

–2.674

0.007**

Ammonia

1.6 (1.2–2.6)

0.1 (0.01–2.25)

2.086

0.037*

Ornithine

89 (59–162.5)

100 (69.5–164.5)

–0.532

0.595

1M Histidine

57 (37–84.5)

4.10 (0.01–114)

–1.581

0.114

3M Histidine

17 (0.01–24.5)

25 (0.65–36.5)

–0.483

0.629

IQR = Interquartile range.
**Highly significant difference, *significant difference.

methylation of DNA and proteins by being a precursor of
S-adenosylmethionine, the universal methyl donor. All
the previous findings raised serious concerns regarding
the long-term effects of restricted diets and emphasized
the importance of early dietary intervention for the
improvement of the developmental outcome in autism
(21,22).
Regarding the measured nonessential amino acids, the
present study recorded a deficiency in the amino acids
tyrosine, cysteine, and serine. These findings could be
interpreted based on the deficiency of the phenylalanine
precursor of tyrosine and deficiency of methionine, the
sulfur donor for endogenous synthesis of cysteine, and they
could be also related to genetic alteration of the biochemical
synthesis pathways (5,19,23). Possible symptoms of low
plasma tyrosine would be learning, memory, or behavioral
disorders and autonomic dysfunction (19). Studies
performed by Main et al. (24) considered cysteine as the
rate-limiting amino acid for the synthesis of glutathione,
which plays a key role in detoxification processes. Such a
finding elucidates the association between autism and the
presence of oxidative stress in such patients (15). Serine is
a critical component in the biosynthesis of acetylcholine,

an important CNS neurotransmitter used in memory
function and a mediator of parasympathetic activity, and
its deficiency was reported to be associated with behavioral
alteration (25).
Moreover, in the present study, autistic children showed
a significantly higher level of glutamic acid as compared
to healthy controls. Similar results were reported by
Ghanizadeh (6), who elucidated the role of glutamic acid
as a major excitatory neurotransmitter in the brain and
considered this hyperglutamatergic state as an etiology
of autism being easily passed through the blood–brain
barrier, hence causing excitotoxicity, neurodegeneration,
and inflammation. Peripherally, glutamate was found to
affect taste sensation, skin pain sensation, and pancreatic
exocrine function (15). The rise in serum glutamic acid
was in part attributed to the failure of its conversion to
glutamine due to vitamin B6 deficiency in such patients
(15), in addition to the modulatory effect of neuroactive
steroids on glutamate level (11). Such findings of high
glutamate led some researchers to consider glutamate as a
diagnostic tool for early detection of autism (26).
The present study demonstrated significantly lower
levels of the nonstandard amino acids α-aminoadipic acid,
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carnosine, and β-alanine and significantly higher levels
of hydroxyproline, phosphoserine, β-amino-isobutyric
acid, and ammonia in autistic children as compared
to healthy controls. A similar finding of high levels of
β-amino-isobutyric acid was reported by Adams et al.
(15), who added that this amino acid is the product of
thymine catabolism; hence, its elevation pointed either
to the increased rate of DNA turnover in autism or to the
inhibition of the conversion of β-amino-isobutyric acid
into its intermediates that eventually lead to the citric
acid cycle. Regarding high levels of plasma ammonia, our
finding was strengthened by Cubała-Kucharska (17), who
attributed this to the impairment of many biochemical
pathways in autism with subsequent failure to detoxify
neuroendotoxins such as ammonia, hence leading to
behavioral and cognitive changes in autism. In contrast to

our study, which reported a nonsignificant difference in
plasma taurine between the two studied groups, Adams
et al. (15) reported lower levels of taurine in autism
and attributed this to the increased wasting of taurine
in urine. Nevertheless, Ghanizadeh (6) demonstrated
increased taurine levels in autism, which was attributed to
a compensatory phenomenon for the increased glutamate
level.
In conclusion, the present study assessed the plasma
amino acid profile in autistic children by cation-exchange
chromatography using postcolumn derivatization by
ninhydrin. The assay revealed that autistic children exhibit
distinct alterations in the plasma levels of some amino
acids, which can in turn participate in the disease etiology
and hence can be applied as a diagnostic tool for early
detection of autism.
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